TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Operating margin 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) operating margin by fiscal year — reported operating income divided by reported revenue.
12.5%FY2025 · since FY2016: 9.8% → 12.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.5% | +14.3 pp |
| FY2024 | -1.8% | -4.6 pp |
| FY2023 | 2.7% | +17.5 pp |
| FY2022 | -14.7% | -25.5 pp |
| FY2021 | 10.8% | +32.2 pp |
| FY2020 | -21.4% | -18.8 pp |
| FY2019 | -2.6% | +6.3 pp |
| FY2018 | -9.0% | +71.0 pp |
| FY2017 | -80.0% | -89.8 pp |
| FY2016 | 9.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice